Cargando…

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination

Mutations that confer low-level fosfomycin resistance (LLFR) but not clinical resistance in Escherichia coli are increasingly reported. LLFR strains can become clinically resistant under urinary tract physiological conditions or may act as gateways for highly resistant subpopulations by the selectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Gutiérrez, Guillermo, Docobo-Pérez, Fernando, Rodríguez-Martínez, Jose Manuel, Pascual, Alvaro, Blázquez, Jesús, Rodriguez-Beltrán, Jeronimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698254/ https://www.ncbi.nlm.nih.gov/pubmed/33198311 http://dx.doi.org/10.3390/antibiotics9110802

Ejemplares similares

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
por: Castañeda-García, Alfredo, et al.
Publicado: (2013)

Glucose-6-phosphate Reduces Fosfomycin Activity Against Stenotrophomonas maltophilia
por: Gil-Gil, Teresa, et al.
Publicado: (2022)

Deciphering pharmacokinetics and pharmacodynamics of fosfomycin
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2019)

Fosfomycin and breastfeeding
Publicado: (2020)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2021)

Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter
por: Hirakawa, Hidetada, et al.
Publicado: (2018)

Fosfomycin in antimicrobial stewardship programs
por: Rubio, Elena Múñez, et al.
Publicado: (2019)

New microbiological aspects of fosfomycin
por: Díez-Aguilar, María, et al.
Publicado: (2019)

The role of fosfomycin in osteoarticular infection
por: Morata, Laura, et al.
Publicado: (2019)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2020)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

1222. Fosfomycin Susceptibility Testing using the new ETEST(®)FO
por: Halimi, Diane, et al.
Publicado: (2020)

Fosfomycin susceptibility of uropathogens at Charlotte Maxeke Johannesburg Academic Hospital
por: Mothibi, Lesego M., et al.
Publicado: (2020)

Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test
por: Croughs, Peter D., et al.
Publicado: (2022)

Fosfomycin in the pediatric setting: Evidence and potential indications
por: Baquero-Artigao, Fernando, et al.
Publicado: (2019)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus
por: Li, Yaowen, et al.
Publicado: (2022)

Fosfomycin: Uses and potentialities in veterinary medicine
por: Pérez, D.S., et al.
Publicado: (2014)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
por: Dijkmans, Anneke Corinne, et al.
Publicado: (2017)

2412. Our Experience With IV Fosfomycin
por: Savaj, Pratik, et al.
Publicado: (2018)

Fosfomycin (Veterinary Medicinal Products): Summary
Publicado: (2019)

Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
por: Leelasupasri, Sombat, et al.
Publicado: (2018)

Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections
por: Rodríguez-Rojas, Alexandro, et al.
Publicado: (2010)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

2062. Evaluation of Susceptibility Testing Methods for Fosfomycin Against Enterobacteriaceae and Pseudomonas aeruginosa
por: De La Cadena, Elsa Piedad, et al.
Publicado: (2018)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Fosfomycin: the characteristics, activity, and use in critical care
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2019)

Oral fosfomycin for the treatment of chronic bacterial prostatitis
por: Karaiskos, Ilias, et al.
Publicado: (2019)

1690. Oral Fosfomycin for the Treatment of Bacterial Prostatitis
por: Kamath, Meghan, et al.
Publicado: (2020)

Acute localized exanthematous pustulosis induced by fosfomycin
por: Alfuraih, Ibrahim, et al.
Publicado: (2023)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
por: Mattioni Marchetti, Vittoria, et al.
Publicado: (2023)

QM/MM Study of the Fosfomycin Resistance Mechanism Involving FosB Enzyme
por: Lima, Anderson H., et al.
Publicado: (2021)

Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
por: Ruiz Ramos, Jesús, et al.
Publicado: (2019)

Fosfomycin, Applying Known Methods and Remedies to A New Era
por: M., Viviana Albán, et al.
Publicado: (2020)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_asv971tr7etrmjsr8k9dj5rlmi